Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 15Sanofi-Aventis Canada Inc.
02 7AstraZeneca Canada Inc.
03 2BGP Pharma ULC
04 5Boehringer Ingelheim (Canada) Ltd.
05 5Gowling Lafleur Henderson LLP
06 7Gowling Strathy & Henderson
07 8Merck Canada Inc.
08 6Pfizer Canada Inc.
09 1Schering-Plough Canada Inc.
10 2Solvay Pharma Inc.
11 10Valeant Canada LP / Valeant Canada S.E.C.
01 31331615
02 31334092
03 31338238
04 51338344
05 51341206
06 31341330
07 32036427
08 32040955
09 22057913
10 22060624
11 32061607
12 12083305
13 12098176
14 12115170
15 32125251
16 42147056
17 32177772
18 12250395
19 52259148
20 12294515
21 22352436
22 52382387
23 52382549
24 12472392
01 4Aliskiren | Hydrochlorothiazide
02 7Candesartan Cilexetil | Hydrochlorothiazide
03 4Eprosartan Mesylate | Hydrochlorothiazide
04 5Irbesartan | Hydrochlorothiazide
05 6Losartan Potassium | Hydrochlorothiazide
06 3Olmesartan medoxomil | hydrochlorothiazide
07 6Quinapril Hydrochloride & Hydrochlorothiazide
08 20Ramipril | Hydrochlorothiazide
09 5Telmisartan | Hydrochlorothiazide
10 8Valsartan | Hydrochlorothiazide
01 4Film Coated Tablets
02 60Tablet
03 4Tablets
01 32011-02-15
02 22011-03-20
03 32011-04-22
04 32011-08-23
05 12011-12-13
06 32012-01-24
07 22012-02-04
08 32012-02-20
09 12012-08-12
10 12012-11-19
11 32013-04-09
12 52013-05-21
13 32014-06-06
14 42015-04-13
15 32016-05-30
16 12017-03-26
17 52017-06-18
18 52018-03-20
19 12018-06-26
20 32019-01-01
21 22020-01-07
22 52020-08-25
23 52020-08-30
24 12022-01-16
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 150 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 300 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE HCT
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 2.5mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.5mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5mg / 25mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10mg / 25mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 150 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 300 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
